Updated hourlyHourly refreshWed, Sep 23, 2026
Press Release Database
Recent press releases, indexed by topic.
Healthcare
HONG KONG, Sept. 17, 2026 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") announced that AK158D1, its investigational next-generation bispecific antibody-drug conjugate (ADC) targeting EGFR and TROP2, has secured Phase I clinical trial clearance from the Center for Drug...
Sep 17 · 06:34·PR Newswire
Healthcare
WHIPPANY, N.J., September 17, 2026--Bayer Summary Bayer today announced that the U.S. Food and Drug Administration (FDA) approved KERENDIA® (finerenone) to reduce urinary albumin-to-creatinine ratio (UACR), which is expected to reduce the risk of sustained estimated glomerular filtration rate (eGFR) decline and end-stage kidney disease in adults with chronic kidney disease (CKD) associated with type 1 diabetes (T1D), following the agency’s Priority Review of the supplemental New Drug Application
Sep 17 · 06:30·mlpr-businesswire
SaaS · Healthcare
ROME, September 17, 2026--The Mediterranean Network for Haemoglobinopathies (MNfH) was recently launched at Palazzo Wedekind in Rome, bringing together leading clinicians and patient representatives from Cyprus, Greece, and Italy, with the Thalassaemia International Federation (TIF). Supported by Avanzanite Bioscience as Founding Sponsor, the independent regional platform will connect expertise across borders, strengthen the patient voice, and turn shared knowledge into practical initiatives tha
Sep 17 · 06:00·mlpr-businesswire
Healthcare
FRANKFURT AM MAIN, Germany, September 17, 2026--Merz Therapeutics, a leading player in neurology-focused specialty pharma, today announced that it has received approval in the European Union (EU) / European Economic Area (EEA) for XEOMIN® (incobotulinumtoxinA) for the symptomatic treatment of spasticity associated with pes equinus, a condition in which tight calf muscles cause the foot to point downward, in ambulant and non-ambulant children and adolescents with cerebral palsy (CP) aged 2 to 17
Sep 17 · 06:00·mlpr-businesswire
Healthcare · Energy
VANCOUVER, British Columbia, September 17, 2026--Nano One® Materials Corp. ("Nano One" or the "Company") (TSX: NANO) (OTCQB: NNOMF) (Frankfurt: LBMB), a process technology company specializing in lithium-ion battery cathode active materials, today announced that Alex Holmes, Chief Executive Officer and a member of the Board of Directors, will be taking a temporary medical leave of absence. The Company expects Mr.
Sep 17 · 05:45·mlpr-businesswire
Healthcare
Piramal Pharma Solutions errichtet an seinem integrierten Standort für Wirkstoffe und Fertigarzneimittel in Morpeth, im Vereinigten Königreich, eine Freiflächen-Solaranlage (4,3 MWp). Die neue Anlage wird den Standort über eine Behind-the-Meter-Konfiguration direkt mit erneuerbarer...
Sep 17 · 05:32·PR Newswire
Finance · Healthcare
MARSEILLE, France, September 17, 2026--Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) ("Innate" or the "Company") today reported its consolidated financial results for the six months ended June 30, 2026. The consolidated financial statements are attached to this press release.
Sep 17 · 05:00·mlpr-businesswire
Healthcare · Education
Sep 17 · 04:30·PressReleaseNews
Healthcare
The Solitary Fibrous Tumor Foundation (SFTF) today announced its launch as the first patient- and supporter-led nonprofit organization dedicated entirely to Solitary Fibrous Tumor (SFT), an ultra-rare sarcoma.The announcement comes during Sarcoma Awareness Month, observed globally each July. SFT is diagnosed in fewer than one in one million people worldwide, with an estimated 300 to 400 new cases in the United States [PR.com]
Sep 17 · 04:07·PR.com
Finance · Healthcare
STOCKHOLM, Sept. 16, 2026 /PRNewswire/ -- Swedish Orphan Biovitrum AB (publ) (Sobi®) and Innate Pharma SA (Euronext Paris: IPH) (NASDAQ: IPHA) ("Innate" or the "Company") today announced that the previously announced strategic partnership with Innate is now effective following the...
Sep 17 · 03:28·PR Newswire
Healthcare
Global Data Route Analytics published a 1,750-page study valuing the global autoinjectors market at USD 13,451.97 million in 2025 and projecting USD 48,029.60 million by 2035, a 13.57% CAGR.
Sep 17 · 02:55·PressReleaseNews
Healthcare
Educator, and writer Veronika Patton will be displayed by the self-publishing and book marketing company ReadersMagnet at an upcoming book festival at Printers Row in Chicago. The outdoor literary festival will take place on September 12-13, along South Dearborn Street in Chicago. - - Designed as a training manual for aspiring yoga teachers and practitioners, “V Yoga Health” shares Veronika's personal journey, meaningful experiences, and valuable teaching lessons. The book encourages re... Read the full story at https://www.webwire.com/ViewPressRel.asp?aId=360483
Sep 17 · 02:04·WebWire